This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Vials of the AstraZeneca COVID-19 vaccine sit in a fridge at the local vaccine center in Ebersberg near Munich, Germany. March, 22, 2021. （The Associated Press/Matthias Schrader/File）
OTTAWA—Health Canada is updating the label for the Oxford-AstraZeneca and COVISHIELD COVID-19 vaccines to add capillary leak syndrome as a potential side-effect.
The agency is also including a warning for patients with a history of the ailment to not get those vaccines.
